Stereotaxis (NYSE:STXS) announced today that it has entered into a collaboration with Abbott (NYSE:ABT) to take robotic electrophysiology to the next level. The collaboration aims to integrate the Abbott EnSite X EP system — a 3D heart mapping system — with Stereotaxis’ robotic magnetic navigation systems. Bringing the Abbott cardiac mapping system together with Stereotaxis’ […]
Stereotaxis
Stereotaxis says system placement delays impacted revenues
Stereotaxis (NYSE:STXS) shares took a hit today on fourth-quarter results that missed the consensus sales forecast. Shares of STXS fell 6.9% to $2.42 apiece in midday trading today.MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — ticked up 1.3%. The St. Louis-based endovascular surgical robot maker posted losses […]
16 surgical robotics companies you need to know
Intuitive remains the dominant surgical robotics company, but corporations ranging from Medtronic to Vicarious Surgical look to compete. Robotic-assisted surgery remains one of the hottest spaces in medtech. Intuitive, which pioneered the field in the 1990s and early 2000s, continues to innovate. At the same time, a host of other companies are looking to compete. […]
Stereotaxis stock up on new orders, progress on next-gen robot
Stereotaxis (NYSE:STXS) today reported third-quarter results that missed on revenue. However, investors reacted positively to a list of positive news from the surgical robotics company. St. Louis–based Stereotaxis lost $5.3 million, or 7¢ per share, off $7.7 million in revenue for the quarter ended Sept. 30, 2022. It lost $5.0 million, or 7¢ per share, […]
Stereotaxis stock down amid cloudy outlook
Stereotaxis (NYSE: STXS) today reported second-quarter revenue that missed Wall Street projections, with the surgical robotics company unable to say how quickly revenue will pick up. Investors reacted by sending STXS shares down more than 18% to $2.10 apiece by late afternoon trading today. The St. Louis–based company lost $5.1 million, or 7¢ per share, […]
Intuitive, Acutus Medical veterans join Stereotaxis
Stereotaxis (NYSE:STXS) announced today that it appointed two new vice presidents who both have extensive industry experience. Frank Van Hyfte will join the St. Louis–based surgical robotics company as VP of Europe, the Middle East and Africa, and Tim Glynn will join as VP of market development. Van Hyfte previously spent more than 15 years […]
Stereotaxis opens new headquarters in St. Louis
Surgical robotics company Stereotaxis (NYSE: STXS) is holding a grand opening today for its 45,000 ft² headquarters facility in downtown St. Louis. The new headquarters is located in the renovated historic Globe Building in St. Louis’s growing Downtown North Urban Insight District. It’s an all-in-one facility housing research and development, advanced manufacturing, and distribution space […]
Study: Stereotaxis robotic technology reduces silent cerebral embolism during AFib ablation
Stereotaxis announced the positive results from a study of its robotic magnetic navigation system in atrial fibrillation ablation. The multi-center, prospective study evaluated 166 patients with paroxysmal or persistent AFib who underwent pulmonary vein isolation using Stereotaxis’ robotic magnetic navigation (RMN) technology or manual contact force ablation catheters. All patients on the study received cerebral […]
Stereotaxis forms partnership to advance electrophysiology robotics in China
Stereotaxis this week announced it has forged a broad collaboration with Shanghai Microport EP Medtech to advance technology innovation and commercial adoption of electrophysiology robotics in China. The agreement combines MicroPort EP’s commercial and product expertise in China’s electrophysiology market and Sterotaxis’s Robotic Magnetic Navigation technology. Through the collaboration, MicroPort EP will be the exclusive […]
Stereotaxis up on Street-beating Q4 results
Shares of Stereotaxis (NYSE:STXS) shot up in morning trading today after the robotic surgery company reported Street-beating Q4 results and predicted double-digit revenue growth this year. The St. Louis–based company, creator of robotic technologies for the treatment of cardiac arrhythmias, reported a loss of –$1.18 million, or –2¢ share, on sales of $6.82 million for the […]
12 surgical robotics companies you need to know
Surgical robotics remains a hot area in medtech — even as it faces headwinds from the COVID-19 pandemic. Intuitive Surgical (NSDQ:ISRG) pioneered robotic surgery through the early 2000s and remains the dominant player, but major companies including Medtronic (NYSE:MDT) and Johnson & Johnson (NYSE:JNJ) have big plans to enter the space and compete. Meanwhile, Stryker (NYSE:SYK) has built a […]
